Over the first two years of implementation, about 7.5 million Medicaid enrollees eligible for cancer screenings will lose coverage, researchers estimate.  

The recall has been designated a Class I, the most serious type. Certain "convenience kits" manufactured by AVID Medical contain non–medical-grade bags that could expose organs to toxins, increasing the odds of a transplant recipient's body rejecting them.

Seventeen Republicans joined Democrats to pass a three-year extension to the tax credits that made medical plans sold through HealthCare.gov cheaper for millions of Americans. However, the GOP passed a competing measure in December that would see the federal government focus on association health plans. It’s unclear if either will find traction in the Senate.

The latest federal jobs report brings good news to healthcare and social assistance, bad news to most other sectors.  

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

AI is an icy landslide sweeping through healthcare. Even surgeons must choose between two stark options: Ride the crest of the powder cloud now or dig yourselves out of a deep runout zone later. 

Numerous “alternative funding programs” are named as defendants in what is a larger challenge of the right of these third-party organizations to import drugs from overseas, bypassing FDA regulations.